Adjusted operating margin is projected in the range of 6% to 8%, with net income per diluted share in the range of $1.23 to $1.81 and adjusted net income per diluted share in the range of $1.85 to ...

At this time, I would like to welcome everyone to the Inspire Medical Systems Fourth Quarter and Full Year 2025 Conference Call. [Operator Instructions] I'll now hand the call over to your first ...

Satyashil Awadhare developed an AI tool to increase large company's revenue and help developers manage and build a strategy for working with AI instead of constantly writing code.

Medical offices bill insurance providers for clients' services. Learn what's involved, including HIPAA regulations, what to ...

Analysts expect Heartflow to report a loss of $0.15 per share for the quarter ended December 2025, representing a significant ...

The pilot represents a key step in CCS's evolution from a traditional distributor to a next-generation chronic care partner. By partnering with SweetSpot, CCS will offer providers a more holistic way ...

Key market opportunities include the growing demand for point-of-care imaging and AI-guided applications, expanding in emergency, primary, and home settings. Strong growth in Asia-Pacific and ...

Shoulder Innovations, Inc. ("Shoulder Innovations") , a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will ...

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and ...

ENVIRONMENT: YOUR expertise in Django & Flask frameworks is wanted by a rapidly growing UK-based Next-gen Telco/VoIP Provider to be its next Python Team Lead. You will lead a team of Developers to ...

ENVIRONMENT: YOUR expertise in Django & Flask frameworks is wanted by a rapidly growing UK-based Next-gen Telco/VoIP Provider to be its next Python Team Lead. You will lead a team of Developers to ...

LCS aims to redefine lung cancer screening by supporting diagnosis at early, curable stages, while reducing false positives to avoid unnecessary follow-up procedures, and has the potential to help ...